{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["B7", "CD80", "CD86", "CTLA4", "SLE", "autoimmune disease", "cytokines"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38050849", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "26"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "12", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1002/cbf.3895"], "Journal": {"ISSN": "1099-0844", "JournalIssue": {"Volume": "42", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan"}}, "Title": "Cell biochemistry and function", "ISOAbbreviation": "Cell Biochem Funct"}, "ArticleTitle": "A better understanding of the role of the CTLA-CD80/86 axis in the treatment of autoimmune diseases.", "Pagination": {"StartPage": "e3895", "MedlinePgn": "e3895"}, "Abstract": {"AbstractText": ["Autoimmune diseases are diseases in which the regulatory mechanisms of the immune response are disturbed. As a result, the body loses self-tolerance. Since one of the main regulatory mechanisms of the immune response is the CTLA4-CD80/86 axis, this hypothesis suggests that autoimmune diseases potentially share a similar molecular basis of pathogenesis. Hence, investigating the CTLA4-CD80/86 axis may be helpful in finding an appropriate treatment strategy. Therefore, this study aims to investigate the molecular basis of the CTLA4-CD80/86 axis in the regulation of the immune response, and then its role in developing some autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, and multiple sclerosis. As well, the main therapeutic strategies affecting the CTLA4-CD80/86 axis have been summarized to highlight the importance of this axis in management of autoimmune diseases."], "CopyrightInformation": "\u00a9 2023 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Darvish", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Laboratory Science Department, College of Science, University of Raparin, Rania, Sulaymaniyah, Iraq."}], "LastName": "Kheder", "ForeName": "Ramiar Kamal", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Sciences, College of Medicine, Hawler Medical University, Erbil, Iraq."}], "LastName": "Faraj", "ForeName": "Tola Abdulsattar", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Analysis, Faculty of Applied Science, Tishk International University, Erbil, Iraq."}], "LastName": "Najmaldin", "ForeName": "Soran K", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center\u066b North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Immunology, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran."}, {"Identifier": [], "Affiliation": "Gastroenterology and Hepatology Research Center, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Nosratabadi", "ForeName": "Reza", "Initials": "R"}, {"Identifier": ["0000-0002-9371-4170"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Esmaeili", "ForeName": "Seyed-Alireza", "Initials": "SA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Biochem Funct", "NlmUniqueID": "8305874", "ISSNLinking": "0263-6484"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "CTLA-4 Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "Antigens, CD"}, {"RegistryNumber": "0", "NameOfSubstance": "B7-2 Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoconjugates"}, {"RegistryNumber": "0", "NameOfSubstance": "B7-1 Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "Cell Adhesion Molecules"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "CTLA-4 Antigen"}, {"QualifierName": [], "DescriptorName": "Antigens, CD"}, {"QualifierName": [], "DescriptorName": "B7-2 Antigen"}, {"QualifierName": [], "DescriptorName": "Immunoconjugates"}, {"QualifierName": ["physiology"], "DescriptorName": "B7-1 Antigen"}, {"QualifierName": ["therapy"], "DescriptorName": "Autoimmune Diseases"}, {"QualifierName": [], "DescriptorName": "Cell Adhesion Molecules"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Xiong T, Turner JE. Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. Semin Immunopathol. 2018;40:393-406."}, {"Citation": "Esmaeili SA, Mahmoudi M, Momtazi AA, Sahebkar A, Doulabi H, Rastin M. Tolerogenic probiotics: potential immunoregulators in systemic lupus erythematosus. J Cell Physiol. 2017;232:1994-2007."}, {"Citation": "Mobasheri L, Nasirpour MH, Masoumi E, Azarnaminy AF, Jafari M, Esmaeili S-A. SARS-CoV-2 triggering autoimmune diseases. Cytokine. 2022;154:155873."}, {"Citation": "Samuels H, Malov M, Saha Detroja T, et al. Autoimmune disease classification based on PubMed text mining. J Clin Med. 2022;11:4345."}, {"Citation": "Van Coillie S, Wiernicki B, Xu J. Molecular and cellular functions of CTLA-4. In: Xu J, ed. Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy. Springer Singapore; 2020:7-32."}, {"Citation": "Esmaeili S-A, Taheri RA, Mahmoudi M, et al. Inhibitory effects of tolerogenic probiotics on migratory potential of lupus patient-derived DCs. Iran J Basic Med Sci. 2021;24:1509-1514."}, {"Citation": "Esmaeili SA, Mahmoudi M, Rezaieyazdi Z, et al. Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics. J Cell Biochem. 2018;119:7865-7872."}, {"Citation": "Rastin M, Mahmoudi M, Tabasi N, Kia N, Hajavi J, Esmaeili S-A. The evaluation of the effect of tolerogenic probiotics on the maturation of healthy dendritic cells versus immature dendritic cells. Iran J\u00a0Immunol. 2023;20:26-35."}, {"Citation": "Krupa P, Spodzieja M, Sieradzan AK. Prediction of CD28-CD86 protein complex structure using different level of resolution approach. J\u00a0Mol\u00a0Graphics Model. 2021;103:107802."}, {"Citation": "Samuels H, Malov M, Saha Detroja T, et al. Autoimmune disease classification based on PubMed Text Mining. J Clin Med. 2022:11(15)4345."}, {"Citation": "Khorasani S, Mahmoudi M, Kalantari MR, et al. Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model. J Cell Physiol. 2019;234:9778-9786."}, {"Citation": "Seitz C, Liu S, Klocke K, et al. Multi-faceted inhibition of dendritic cell function by CD4(+)Foxp3(+) regulatory T cells. J Autoimmun. 2019;98:86-94."}, {"Citation": "Hosseini A, Gharibi T, Marofi F, Babaloo Z, Baradaran B. CTLA-4: from mechanism to autoimmune therapy. Int Immunopharmacol. 2020;80:106221."}, {"Citation": "Liu W, Yang Z, Chen Y, et al. The association between CTLA-4, CD80/86, and CD28 gene polymorphisms and rheumatoid arthritis: an original study and meta-analysis. Front Med. 2021;8:598076."}, {"Citation": "Kennedy A, Waters E, Rowshanravan B, et al. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation. Nat\u00a0Immunol. 2022;23:1365-1378."}, {"Citation": "Chikuma S. CTLA-4, an essential immune-checkpoint for T-cell activation. Curr Top Microbiol Immunol. 2017;410:99-126."}, {"Citation": "Soskic B, Jeffery LE, Kennedy A, et al. CD80 on human T cells is associated with FoxP3 expression and supports treg homeostasis. Front Immunol. 2021;11:577655."}, {"Citation": "Sansom DM, Walker LSK. Dimers aren't forever: CD80 breaks up with PD-L1. Immunity. 2019;51:972-974."}, {"Citation": "Chattopadhyay G, Shevach EM. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism. J\u00a0Immunol. 2013;191:5875-5884."}, {"Citation": "Halliday N, Williams C, Kennedy A, et al. CD86 is a selective CD28 ligand supporting FoxP3+ regulatory T cell homeostasis in the presence of high levels of CTLA-4. Front Immunol. 2020;11:600000."}, {"Citation": "Chen R, Ganesan A, Okoye I, et al. Targeting B7-1 in immunotherapy. Med Res Rev. 2020;40:654-682."}, {"Citation": "Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev. 2009;229:12-26."}, {"Citation": "Brzostek J, Gascoigne NRJ, Rybakin V. Cell type-specific regulation of immunological synapse dynamics by B7 ligand recognition. Front Immunol. 2016;7:24."}, {"Citation": "Kowalczyk A, D'Souza CA, Zhang L. Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3. Eur J Immunol. 2014;44:1143-1155."}, {"Citation": "Van Coillie S, Wiernicki B, Xu J. Molecular and cellular functions of CTLA-4. Adv Exp Med Biol. 2020;1248:7-32."}, {"Citation": "Wakamatsu E, Mathis D, Benoist C. Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells. Proc\u00a0Natl Acad\u00a0Sci. 2013;110:1023-1028."}, {"Citation": "Tekguc M, Wing JB, Osaki M, Long J, Sakaguchi S. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells. Proc\u00a0Natl Acad\u00a0Sci. 2021;118:e2023739118."}, {"Citation": "Yalcin AD, Gorczynski RM, Kahraman MS, Demirel MU, Terzioglu E. CD40, CD45 CTLA-4 levels are elevated in healthy older adults. Clin Lab. 2012;58:449-456."}, {"Citation": "Shinoyama M, Ideguchi M, Hayashi H, et al. Cytotoxic T lymphocyte antigen 4 immunogloblin promotes neuronal differentiation in the grafts of embryonic stem cell-derived neural precursor cells. Neuroscience. 2012;202:484-491."}, {"Citation": "Sug\u00e1r IP, Das J, Jayaprakash C, Sealfon SC. Multiscale modeling of complex formation and CD80 depletion during immune synapse development. Biophys J. 2017;112:997-1009."}, {"Citation": "Qureshi OS, Zheng Y, Nakamura K, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332:600-603."}, {"Citation": "Ertelt JM, Buyukbasaran EZ, Jiang TT, Rowe JH, Xin L, Way SS. B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells. J Leukoc Biol. 2013;94:367-376."}, {"Citation": "Khailaie S, Rowshanravan B, Robert PA, et al. Characterization of CTLA4 trafficking and implications for its function. Biophys J. 2018;115:1330-1343."}, {"Citation": "Shakerian L, Kolahdooz H, Garousi M, et al. IL-33/ST2 axis in autoimmune disease. Cytokine. 2022;158:156015."}, {"Citation": "Yang L, Wang G, Xia H. Molecular mechanism for impaired suppressive function of Tregs in autoimmune diseases: a summary of cell-intrinsic and cell-extrinsic factors. J Cell Mol Med. 2020;24:11056-11063."}, {"Citation": "Tai Y, Wang Q, Korner H, Zhang L, Wei W. Molecular mechanisms of T cells activation by dendritic cells in autoimmune diseases. Front Pharmacol. 2018;9:642."}, {"Citation": "Tzeng HT, Chyuan IT, Lai JH. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: a focus on molecular mechanisms and therapeutic potential. Biochem Pharmacol. 2021;193:114760."}, {"Citation": "de Almeida ERA, Petzl-Erler ML. Expression of genes involved in susceptibility to multifactorial autoimmune diseases: estimating genotype effects. Int J Immunogenet. 2013;40:178-185."}, {"Citation": "Saverino D, Simone R, Bagnasco M, Pesce G. The soluble CTLA-4 receptor and its role in autoimmune diseases: an update. Autoimmun\u00a0Highlights. 2010;1:73-81."}, {"Citation": "Zaremehrjardi F, Baniadam L, Seif F, et al. A patient with CTLA-4 haploinsufficiency with multiple autoimmune presentations: a case report. Iran\u00a0J\u00a0Immunol. 2020;17:244-249."}, {"Citation": "Crepeau RL, Ford ML. Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity. Expert Opin Biol Ther. 2017;17:1001-1012."}, {"Citation": "Kristiansen O, Larsen Z, Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun. 2000;1:170-184."}, {"Citation": "Wenbin L, Jiawen L. Expression of CD80/CD86 and CTLA-4 mRNA in peripheral blood mononuclear cells of the patients with systemic lupus erythematosus. J\u00a0Huazhong Univ\u00a0Sci\u00a0Technol\u00a0Med\u00a0Sci. 2004;24:247-249."}, {"Citation": "Hirashima M, Fukazawa T, Abe K, Morita Y, Kusaoi Mand Hashimoto H. Expression and activity analyses of CTLA4 in peripheral blood lymphocytes in systemic lupus erythematosus patients. Lupus. 2004;13:24-31."}, {"Citation": "Romo-Tena J, G\u00f3mez-Mart\u00edn D, Alcocer-Varela J. CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance. Autoimmun Rev. 2013;12:1171-1176."}, {"Citation": "Zhao L, Zhou X, Zhou X, et al. Low expressions of PD-L1 and CTLA-4 by induced CD4(+)CD25(+) Foxp3(+) Tregs in patients with SLE and their correlation with the disease activity. Cytokine. 2020;133:155119."}, {"Citation": "Garc\u00eda-C\u00f3zar FJ, Molina IJ, Cuadrado MJ, Marubayashi M, Pe\u00f1a J, Santamar\u00eda M. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol. 1996;104:72-79."}, {"Citation": "Garin EH, Diaz LN, Mu W, et al. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol. 2009;20:260-266."}, {"Citation": "Parietti V, Monneaux F, D\u00e9cossas M, Muller S. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Arthritis Rheumat. 2008;58:1751-1761."}, {"Citation": "Liu CP, Jiang JA, Wang T, et al. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China. Genet Mol Res. 2013;12:1373-1382."}, {"Citation": "Webb LMC, Walmsley MJ, Feldmann M. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol. 1996;26:2320-2328."}, {"Citation": "Verwilghen J, Lovis R, De Boer M, et al. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J\u00a0Immunol. 1994;153:1378-1385."}, {"Citation": "Summers KL, O'Donnell JL, Williams LA, Hart DNJ. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis. Arthritis Rheumat. 1996;39:1287-1291."}, {"Citation": "Wan B, Nie H, Liu A, et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J\u00a0Immunol. 2006;177:8844-8850."}, {"Citation": "Cao J, Zou L, Luo P, Chen P, Zhang L. Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis. Int Immunopharmacol. 2012;14:585-592."}, {"Citation": "Srinivasan M, Eri R, Zunt SL, Summerlin DJ, Brand DD, Blum JS. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent. Arthritis Rheumat. 2007;56:498-508."}, {"Citation": "Dahl\u00e9n E, Hedlund G, Dawe K. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J\u00a0Immunol. 2000;164:2444-2456."}, {"Citation": "Spatz M, Eibl N, Hink S, et al. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell Immunol. 2003;221:15-26."}, {"Citation": "Chang TT, Kuchroo VK, Sharpe AH. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Curr Dir Autoimmun. 2002;5:113-130."}, {"Citation": "Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000;12:431-440."}, {"Citation": "Fife BT. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J Clin Invest. 2006;116:2252-2261."}, {"Citation": "Wagner M, Sobczy\u0144ski M, Karabon L, et al. Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset. J Neuroimmunol. 2015;288:79-86."}, {"Citation": "Hallal DEM, Farias AS, Oliveira EC, et al. Costimulatory molecule expression on leukocytes from mice with experimental autoimmune encephalomyelitis treated with IFN-\u03b2. J Interferon Cytokine Res. 2003;23:293-298."}, {"Citation": "Mena E, Rohowsky-Kochan C. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis. Acta Neurol Scand. 1999;100:92-96."}, {"Citation": "Han L, Shen L, Zhu Y, Qiu Y. A monoclonal antibody against CD86 and its protection in a murine lupus nephritis model of chronic graft-versus-host disease. Immunopharmacol Immunotoxicol. 2017;39:285-291."}, {"Citation": "Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science. 1994;265:1225-1227."}, {"Citation": "Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225-252."}, {"Citation": "Huang C, Zhang L, Ling F, et al. Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: an in vivo study. Exp Ther Med. 2018;15:2499-2506."}, {"Citation": "Guiteras J, Crespo E, Fontova P, et al. Dual costimulatory and coinhibitory targeting with a hybrid fusion protein as an immunomodulatory therapy in lupus nephritis mice models. Int J Mol Sci. 2022;23(15):8411."}, {"Citation": "Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest. 1995;96:987-993."}, {"Citation": "Lenschow DJ, Ho SC, Sattar H, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med. 1995;181:1145-1155."}, {"Citation": "Perez N, Karumuthil-Melethil S, Li R, Prabhakar BS, Holterman MJ, Vasu C. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation. J\u00a0Immunol. 2008;180:6566-6576."}, {"Citation": "Prud'homme GJ, Chang Y, Li X. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand. Hum Gene Ther. 2002;13:395-406."}, {"Citation": "Spanier JA, Nashold FE, Nelson CD, Praska CE, Hayes CE. Vitamin D(3)-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D(3) synthesis and correlates with increased CD4(+) T cell CTLA-4 expression. J Neuroimmunol. 2020;338:577105."}, {"Citation": "Perrin PJ, Lovett-Racke A, Phillips SM, Racke MK. Differential requirements of na\u00efve and memory T cells for CD28 costimulation in autoimmune pathogenesis. Histol\u00a0Histopathol. 1999;14:1269-1276."}, {"Citation": "Espejo C, Brieva L, Ruggiero G, R\u00edo J, Montalban X, Mart\u00ednez-C\u00e1ceres EM. IFN-\u03b2 treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis. Multiple Scler\u00a0J. 2004;10:630-635."}, {"Citation": "Linsley PS. The CD28/CTLA-4:B7 receptor system in experimental autoimmune encephalomyelitis. J Clin Invest. 1995;95:2429-2430."}, {"Citation": "Radmanesh F, Mahmoudi M, Yazdanpanah E, et al. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life. 2020;72:2366-2381."}, {"Citation": "Vahidi Z, Samadi M, Mahmoudi M, et al. Lactobacillus rhamnosus and Lactobacillus delbrueckii ameliorate the expression of miR-155 and miR-181a in SLE patients. J\u00a0Funct\u00a0foods. 2018;48:228-233."}, {"Citation": "Yazdanpanah E, Mahmoudi M, Sahebari M, et al. Vitamin D3 alters the expression of toll-like receptors in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. J Cell Biochem. 2017;118:4831-4835."}, {"Citation": "Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica. 2011;6:330-336."}, {"Citation": "Mohammadi B, Saghafi M, Abdulsattar Faraj T, Kamal Kheder R, Sajid Abdulabbas H, Esmaeili SA. The role of tolerogenic dendritic cells in systematic lupus erythematosus progression and remission. Int Immunopharmacol. 2023;115:109601."}, {"Citation": "Tian Z, Gershwin ME, Zhang C. Regulatory NK cells in autoimmune disease. J Autoimmun. 2012;39:206-215."}, {"Citation": "Hoseinzadeh A, Rezaieyazdi Z, Mahmoudi M, et al. Dysregulated balance in Th17/Treg axis of pristane-induced lupus mouse model,\u00a0are mesenchymal stem cells therapeutic? Int Immunopharmacol. 2023;117:109699."}, {"Citation": "Lu F, Zhu M, Lin Y, et al. The preliminary efficacy evaluation of the CTLA-4-Ig treatment against Lupus nephritis through in-silico analyses. J Theor Biol. 2019;471:74-81."}, {"Citation": "Ahmadi P, Mahmoudi M, Kheder RK, et al. Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity. Int Immunopharmacol. 2023;118:109936."}, {"Citation": "Ramezani M, Zainodini N, Nosratabadi R, et al. Phytosomal curcumin alleviates collagen-induced arthritis by downregulating Th17 and upregulating Treg cell responses in rats. Asian Pac J Trop Biomed. 2022;12:466."}, {"Citation": "Liu M, Yu Y, Hu S. A review on applications of abatacept in systemic rheumatic diseases. Int Immunopharmacol. 2021;96:107612."}, {"Citation": "Marquez Pete N, Maldonado Montoro MM, P\u00e9rez Ram\u00edrez C, et al. Impact of single-nucleotide polymorphisms of CTLA-4, CD80 and CD86 on the effectiveness of abatacept in patients with rheumatoid arthritis. J Pers Med. 2020;10:220."}, {"Citation": "Oi K, Tokunaga T, Kuranobu T, et al. Tumour necrosis factor \u03b1 augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression. Clin Exp Immunol. 2019;196:392-402."}, {"Citation": "Lorenzetti R, Janowska I, Smulski CR, et al. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. J Autoimmun. 2019;101:145-152."}, {"Citation": "Hassanshahi G, Roohi MA, Esmaeili S-A, Pourghadamyari H, Nosratabadi R. Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal stem cells in multiple sclerosis patients. Cytokine. 2021;148:155706."}, {"Citation": "Jan Z, Mollazadeh S, Abnous K, et al. Targeted delivery platforms for the treatment of multiple sclerosis. Mol Pharmaceutics. 2022;19:1952-1976."}, {"Citation": "Atabati H, Yazdanpanah E, Mortazavi H, et al. Immunoregulatory effects of tolerogenic probiotics in multiple sclerosis. In: Guest PC, ed. Reviews on New Drug Targets in Age-Related Disorders: Part II. Springer Cham; 2021:87-105."}, {"Citation": "Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Mahmoudi M. Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells. Nanomedicine. 2016;12:1961-1971."}, {"Citation": "Mahmoudi M, Rastin M, Kazemi Arababadi M, Anaeigoudari A, Nosratabadi R. Enhancing the efficacy of Hypericum perforatum in the treatment of an experimental model of multiple sclerosis using gold nanoparticles: an in vivo study. Avicenna J Phytomed. 2022;12:325-336."}, {"Citation": "Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest. 1998;101:725-730."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "11", "Day": "10"}, {"Year": "2023", "Month": "8", "Day": "27"}, {"Year": "2023", "Month": "11", "Day": "17"}, {"Year": "2024", "Month": "1", "Day": "26", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "12", "Day": "5", "Hour": "17", "Minute": "44"}, {"Year": "2023", "Month": "12", "Day": "5", "Hour": "6", "Minute": "53"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38050849", "10.1002/cbf.3895"]}}], "PubmedBookArticle": []}